| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adipose tissue inflammation and liver pathology in human obesity
|
Tordjman, J.
|
|
2008
|
34 |
6P2 |
p. 658-663
6 p.
|
article
|
| 2 |
Cannabinoid receptors as novel therapeutic targets for the management of non-alcoholic steatohepatitis
|
Mallat, A.
|
|
2008
|
34 |
6P2 |
p. 680-684
5 p.
|
article
|
| 3 |
Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis
|
Serfaty, L.
|
|
2008
|
34 |
6P2 |
p. 634-637
4 p.
|
article
|
| 4 |
Definition and natural history of metabolic steatosis: histology and cellular aspects
|
Paradis, V.
|
|
2008
|
34 |
6P2 |
p. 638-642
5 p.
|
article
|
| 5 |
Editorial
|
Girard, Jean
|
|
2008
|
34 |
6P2 |
p. 633-
1 p.
|
article
|
| 6 |
Hepatitis C virus and glucose and lipid metabolism
|
Alaei, M.
|
|
2008
|
34 |
6P2 |
p. 692-700
9 p.
|
article
|
| 7 |
How to measure hepatic insulin resistance?
|
Choukem, S.-P.
|
|
2008
|
34 |
6P2 |
p. 664-673
10 p.
|
article
|
| 8 |
Insulin resistance and steatosis in humans
|
Capeau, J.
|
|
2008
|
34 |
6P2 |
p. 649-657
9 p.
|
article
|
| 9 |
Non-invasive diagnosis of steatosis and fibrosis
|
Castera, L.
|
|
2008
|
34 |
6P2 |
p. 674-679
6 p.
|
article
|
| 10 |
The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis
|
Cariou, B.
|
|
2008
|
34 |
6P2 |
p. 685-691
7 p.
|
article
|
| 11 |
The role of the lipogenic pathway in the development of hepatic steatosis
|
Postic, C.
|
|
2008
|
34 |
6P2 |
p. 643-648
6 p.
|
article
|
Journal description